CareRx stock forecast
CareRx (29C1) Stock Forecast & Price Target
29C1 Analyst Ratings
29C1 Stock 12 Month Forecast
Average Price Target
€2.62▲(39.42% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Justin Keywood | Stifel Nicolaus | €2.70 | buy | 43.65%Upside | Reiterated | 11/06/26 | ||
| Tania Armstrong-Whitworth | Canaccord Genuity | €2.86→€2.54 | buy | 35.20%Upside | Reiterated | 11/06/26 | ||
| David Martin PhD | Bloom Burton | €3.18 | buy | 69.00%Upside | Reiterated | 07/31/26 | ||
| Kyle McPhee | ATB Cormark Capital Markets | €3.97 | buy | 111.24%Upside | Reiterated | 05/11/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Justin KeywoodStifel Nicolaus | BuyReiterated€2.70 | 11/06/26 | 43.65%Upside | ||
| Tania Armstrong-WhitworthCanaccord Genuity | BuyReiterated€2.86→€2.54 | 11/06/26 | 35.20%Upside | ||
| David Martin PhDBloom Burton | BuyReiterated€3.18 | 07/31/26 | 69.00%Upside | ||
| Kyle McPheeATB Cormark Capital Markets | BuyReiterated€3.97 | 05/11/26 | 111.24%Upside |
Best Analysts Covering CareRx
Copying Tania Armstrong-Whitworth's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +9.30% per trade.
Copying David Martin PhD's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +21.79% per trade.
Copying David Martin PhD's trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of +37.43% per trade.
29C1 Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 0 | 0 | 0 | 0 |
| Buy | 4 | 2 | 2 | 0 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 5 | 2 | 2 | 0 | 2 |
In the current month, 29C1 has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 29C1 average Analyst price target in the past 3 months is 2.62.
29C1 Financial Forecast
29C1 Earnings Forecast
Next quarter’s earnings estimate for 29C1 is EUR 0.02 with a range of EUR 0.01 to EUR 0.04. The previous quarter’s EPS was EUR 0.00. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
29C1 Sales Forecast
Next quarter’s sales forecast for 29C1 is EUR 61.45M with a range of EUR 60.78M to EUR 62.98M. The previous quarter’s sales results were EUR 60.26M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
